ResVita Bio is developing therapeutics for skin diseases. Their unique science involves utilizing genetically engineered bacteria to produce and deliver therapeutic proteins directly to affected areas of the skin. This offers a dynamic and sustained delivery system, overcoming the common challenges of stability and short half-lives of traditional protein therapies, since bacterial therapeutics are living systems that can continuously synthesize and secrete therapeutic agents. ResVita Bio's platform can be applied to a wide range of skin diseases, and they are starting with Netherton Syndrome and Severe Atopic Dermatitis.

<p>Claim company profile to add description to this page.</p>


ResVita Bio

Founded: 2021
Location: Berkeley, CA
Employee range: 1 - 10
Clinical stage: RD
Therapy area: Skin diseases
Drug types: DRM, INF
Lead product: Undisclosed
Funding: not disclosed

Business:

About:

Jobs:

News: